Literature DB >> 6188409

Development of a radioimmunoassay for pregnancy-associated plasma protein A and establishment of normal levels in the first trimester of pregnancy.

F Anthony, G M Masson, P J Wood.   

Abstract

An accelerated double antibody method has been developed for the radioimmunoassay of pregnancy-associated plasma protein A (PAPP-A) in serum. The workable range for the assay was 0.04-1.8 mg/l of serum. PAPP-A levels were determined in single serum samples from 110 women with prospective normal pregnancies of between 7 and 14 weeks' gestation. The level of pregnancy specific beta 1 glycoprotein (SP1) was also measured in these samples and normal ranges for PAPP-A and SP1 were constructed from the results obtained.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188409     DOI: 10.1177/000456328302000104

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  4 in total

1.  The development and validation of a radioimmunoassay for human pregnancy-associated plasma protein A (PAPP-A).

Authors:  L G Pinto Furtado; A E Bolton; J G Grudzinskas; M G Chapman; M J Sinosich; V Sharma
Journal:  Arch Gynecol       Date:  1984

2.  Enzyme immunometric assay for the determination of pregnancy associated plasma protein A (PAPP-A) with the antigen as solid phase (conjoint IEMA).

Authors:  N A Bersinger
Journal:  Experientia       Date:  1984-09-15

3.  Widespread divergence of the CEACAM/PSG genes in vertebrates and humans suggests sensitivity to selection.

Authors:  Chia Lin Chang; Jenia Semyonov; Po Jen Cheng; Shang Yu Huang; Jae Il Park; Huai-Jen Tsai; Cheng-Yung Lin; Frank Grützner; Yung Kuei Soong; James J Cai; Sheau Yu Teddy Hsu
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

4.  A carcinogenic potency database of the standardized results of animal bioassays.

Authors:  L S Gold; C B Sawyer; R Magaw; G M Backman; M de Veciana; R Levinson; N K Hooper; W R Havender; L Bernstein; R Peto
Journal:  Environ Health Perspect       Date:  1984-12       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.